Instil Bio, Inc.

NASDAQ:TIL

Biotechnology

Healthcare
$7.45 +0.13%

+$0.01 today

Market cap
$50.53M
Beta
1.91
P/E (TTM)
-1.1
EPS (TTM)
-$6.99
52W Low $5.67High $33.83

Volume 0.02M

Average 0.03M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$36.62M

FY 2025 · Annual

Investing Cash Flow

$25.48M

FY 2025 · Annual

-52.8% YoY

Financing Cash Flow

$7.29M

FY 2025 · Annual

+315.5% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(156.79M)(223.18M)(156.09M)(74.14M)(71.37M)
Depreciation & Amortization2.75M5.99M4.76M3.61M534K
Deferred Income Tax710K0000
Stock-Based Compensation26.2M30.44M18.17M17.26M8.69M
Change in Working Capital4.36M(9.57M)(9.02M)(12.61M)(560K)
Accounts Receivables0000(3.4M)
Inventory00000
Accounts Payables3.86M(1.81M)(1.13M)(556K)116K
Other Working Capital499K(7.76M)(7.89M)(12.05M)2.72M
Other Non-Cash Items636K16.15M60.15M10.18M26.09M
Operating Cash Flow(122.14M)(180.16M)(82.03M)(55.7M)(36.62M)
Capital Expenditures(57.83M)(84.59M)(20.66M)(10M)0
Acquisitions (Net)01.17M00432K
Purchases of Investments(1.11B)(666.22M)(301.47M)(135.6M)(100.86M)
Sales of Investments691M865.35M361.7M198.71M135.9M
Other Investing Activities0(1.17M)1.56M866K0
Investing Cash Flow(474.4M)114.54M41.13M53.97M25.48M
Debt Repayment070.34M8.08M2.76M6.61M
Common Stock Issued339.02M1.55M00853K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities1.69M00(1.01M)(172K)
Financing Cash Flow393.16M71.89M8.08M1.76M7.29M
Effect of Forex Changes(304K)(637K)(201K)(94K)20K
Net Change in Cash(203.67M)5.63M(33.02M)(61K)(3.83M)
Free Cash Flow(179.97M)(264.75M)(102.69M)(65.7M)(36.62M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$71.4M
+ D&A$534.0K
+ Stock-Based Comp$8.7M
+ Deferred Tax$0
- Working Capital-$560.0K
+ Other Non-Cash$26.1M
= Operating Cash Flow-$36.6M
- Capex$0
= Free Cash Flow-$36.6M

Analysis

FY2025 free cash flow is -$36.6M. FCF conversion is 51.3% of net income. Operating cash flow was -$36.6M, with capex of $0. The largest bridge item is Other Non-Cash at $26.1M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportAug 13, 2026
8-KCurrent reportAug 13, 2026
4Statement of changes in beneficial ownershipJun 12, 2026
4Statement of changes in beneficial ownershipJun 12, 2026
4Statement of changes in beneficial ownershipJun 12, 2026

Does TIL generate free cash flow?

Instil Bio, Inc. (TIL) generated -$36.62M of free cash flow in fiscal 2025.

How much operating cash flow does TIL produce?

Operating cash flow was -$36.62M, before capital expenditures of $0.00.